219 related articles for article (PubMed ID: 3145794)
1. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
[TBL] [Abstract][Full Text] [Related]
2. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
[TBL] [Abstract][Full Text] [Related]
3. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
4. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats.
Gunness-Hey M; Hock JM
Bone; 1989; 10(6):447-52. PubMed ID: 2624826
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
Hock JM; Gunness-Hey M; Poser J; Olson H; Bell NH; Raisz LG
Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats.
Gera I; Hock JM; Gunness-Hey M; Fonseca J; Raisz LG
Calcif Tissue Int; 1987 Apr; 40(4):206-11. PubMed ID: 3107773
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
Burnatowska-Hledin MA; Doyle TM; Eadie MJ; Mayor GH
J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
[TBL] [Abstract][Full Text] [Related]
8. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
Hock JM; Hummert JR; Boyce R; Fonseca J; Raisz LG
J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
[TBL] [Abstract][Full Text] [Related]
9. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.
Gunness-Hey M; Hock JM
Metab Bone Dis Relat Res; 1984; 5(4):177-81. PubMed ID: 6738355
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ
Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
[TBL] [Abstract][Full Text] [Related]
11. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone does not enhance the anabolic effect of human parathyroid hormone (1-34) on bone in aging multiparous and virgin rats.
Hock JM; Wood RJ
Mech Ageing Dev; 1995 Nov; 85(2-3):183-97. PubMed ID: 8786664
[TBL] [Abstract][Full Text] [Related]
17. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet.
Goulding A; Gold E; Fisher L
Bone Miner; 1990 Mar; 8(3):185-93. PubMed ID: 2322693
[TBL] [Abstract][Full Text] [Related]
18. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
19. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone.
Hock JM; Fonseca J
Endocrinology; 1990 Oct; 127(4):1804-10. PubMed ID: 2401235
[TBL] [Abstract][Full Text] [Related]
20. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
